Perspectives for the future
In the future, physicians will be able to provide more personalized
treatments to patients based on their genomic profiles. As this new
approach to patient care and personalized medicine continues, a large
amount of genomic data on patients will be available. The research can
be used to guide best practices across a wide range of indications and
create patient success stories [3].
In the future, medicine will become an information science. Information
processing is an essential component of health-care, which extends
beyond simply converting medical and genomic data to digital formats.
Over the next 10 years, we may have an enormous amount of data on each
individual. It is IT (Information Technology) hardware or software that
can turn that into real hypotheses about each patient [32].
The use of Personalized Medicines will result in more affordable and
effective healthcare, access to novel biomedical methods, and a better
grasp of one’s own health and genomic information by individuals as well
as economic growth in the healthcare sector [33].
Many prescription medicines are ineffective for many people. In 2015,
the top 10 grossing pharmaceutical products in the US only benefited 23
to 1 in 4 people. The worst thing about this drug is that sometimes
drugs may not work, but may still cause side effects.
In the pipeline, 45% of new medicines can be personalized. Seventy-five
percent of cancer drugs could be customized. The expected increase in
personalised medicine investment over the next 5 years is 35 percent.
Conclusion
There is still much to learn about personalizing medicine. In the
present era of healthcare, it is possible to select medication based on
a patient’s genetic makeup, which reduces adverse side effects and
ensures better health. In the future, personalized medications could
have a positive impact on the healthcare system by providing each
person’s full genomic profile details on the day of their birth to put
into an individual healthcare record. Clinicians and doctors will be
able to adopt more reliable and efficient healthcare approaches using
genomic data based on patient exposure to multiple diseases. In the
future, only firms that invest in pharmacogenomics and personalized
medicine will be able to survive in the pharmaceutical industry. Genetic
profiles will be linked to large knowledge bases in order to offer
custom-designed diagnosis and treatment to individual patients. In the
future, different diagnostic tools will be used to identify and evaluate
diseases at various stages. Furthermore, this will also be an
opportunity for new players to enter the Pharmaceutical market by
bringing innovative ideas to the market. In the future, the
pharmaceutical market will shift from a mass market to one that offers
specialized products.
Conflict of Interest Statement : The authors report no conflicts
of interest. The authors alone are responsible for the content and
writing of this article.